Riskpilot← Back to searchSign inGet full accessS Snabbdoktor AB
ABActiveOrg 5590023429Kungsgatan 43General medical practice activities · NACE 8621Est. 201523 employees
Revenue 2025
SEK 62,6M
+16% vs 2024
EBITDA margin
2.0%
+24% vs 2024
Equity ratio
10.4%
Financial strength
Net profit 2025
SEK 445K
-14% vs 2024
| Revenue | SEK 62,6M | +16% |
| EBITDA | SEK 1,2M | +24% |
| Net profit | SEK 445K | -14% |
| Total assets | SEK 9,1M | +9% |
| Equity | SEK 940K | +58% |
| Employees | 23 | — |
Legal name
S Snabbdoktor AB
Org number
5590023429
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
2 februari 2015
Share capital
SEK 50 000
Employees
23 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Primärvårdsmottagning.
Address
Kungsgatan 43
Email
kontakt@snabbdoktor.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 2 232 | 1 439 | 31 910 | 53 859 | 62 567 |
| Staff expenses | — | −1 733 | −7 872 | −14 766 | −16 457 |
| EBITDA | −169 | −1 161 | 1 596 | 1 006 | 1 246 |
| Depreciation & amort. | −96 | −101 | −353 | −310 | −440 |
| EBIT | −265 | −1 262 | 1 244 | 696 | 806 |
| Net financials | −6 | −15 | −222 | −181 | −174 |
| Profit before tax | −271 | −1 277 | 1 021 | 515 | 516 |
| Tax | −0 | — | — | — | −72 |
| Net profit | −271 | −1 277 | 1 021 | 515 | 445 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 252 | 790 | 7 163 | 8 320 | 9 054 |
| Equity | −64 | −1 341 | 80 | 595 | 940 |
| Long-term debt | 0 | 1 550 | 2 644 | 1 617 | 923 |
| Short-term debt | 300 | 566 | 4 424 | 6 108 | 7 077 |
| Total debt | 300 | 2 116 | 7 068 | 7 725 | 7 999 |
EBITDA margin
2.0%
This company
15.8%
Market median
-87% vs market
20212025
Equity ratio
10.4%
This company
38.2%
Market median
-73% vs market
20212025
Return on equity
47.3%
This company
18.4%
Market median
+157% vs market
20212025
Net profit margin
0.7%
This company
8.1%
Market median
-91% vs market
20212025
Asset turnover
6.91×
This company
1.12×
Market median
+517% vs market
20212025
Debt / equity
8.63×
This company
0.62×
Market median
-1292% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
SL Chief Auditor | Chief Auditor | 2025 |
KA Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2025 | |
| Chairman | 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
S Snabbdoktor AB 
S Snabbkollen ABBoard members of S Snabbdoktor AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Siv Lilian Marie Andersson | Chief Auditor | 0 companies |
| Karim Almohtasib | Deputy Chief Executive Officer | 0 companies |
| Tarik Almohtasib | Board of Directors | 0 companies |
| Mahmoud Almohtasib | Chairman | 0 companies |